Celler Therapeutics Sdn Bhd is a Malaysian biotechnology company specialising in regenerative medicine and advanced cell-based therapies. The core business revolves around research, development, and biomanufacturing of innovative treatments designed to address chronic and life-threatening conditions such as Type 2 diabetes and cardiovascular diseases.

By harnessing cutting-edge biotechnology, the company aims to redefine healthcare possibilities and improve patient outcomes. Positioned within Malaysia’s growing life sciences ecosystem, Celler Therapeutics focuses on translating scientific breakthroughs into practical medical solutions, striving to deliver transformative therapies that contribute to both national biomedical progress and global healthcare innovation.